Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where S. Borgwardt is active.

Publication


Featured researches published by S. Borgwardt.


Neuroscience & Biobehavioral Reviews | 2012

Multimodal meta-analysis of structural and functional brain changes in first episode psychosis and the effects of antipsychotic medication

Joaquim Radua; S. Borgwardt; A. Crescini; David Mataix-Cols; Andreas Meyer-Lindenberg; Philip McGuire; Paolo Fusar-Poli

Structure and function in the human brain are closely related. At the onset of psychosis, brain imaging studies have identified robust changes in brain function and structure, but no data are available relating these two domains. After systematic literature searches, we included all available studies reporting whole-brain structural or cognitive functional imaging findings in first-episode (FEP) subjects in multimodal Signed Differential Mapping (SDM). Forty-three studies met the inclusion criteria. The structural database comprised 965 FEP subjects matched with 1040 controls whilst the functional cohort included 362 FEP subjects matched with 403 controls. The analysis identified conjoint structural and functional differences in the insula/superior temporal gyrus and the medial frontal/anterior cingulate cortex bilaterally. In these regions, large and robust decreases in grey matter volume were found with either reduced or enhanced activation. Meta-regression analyses indicated that grey matter volume in the anterior cingulate and left insular clusters was influenced by exposure to antipsychotics: patients receiving medication were more likely to show structural abnormalities in these regions.


Acta Psychiatrica Scandinavica | 2007

The Basel early-detection-of-psychosis (FEPSY)-study - design and preliminary results

Anita Riecher-Rössler; Ute Gschwandtner; Jacqueline Aston; S. Borgwardt; M. Drewe; Peter Fuhr; Marlon Pflüger; W. Radü; Ch. Schindler; Rolf-Dieter Stieglitz

Objective:  Early detection and therapy of schizophrenic psychoses have become broadly accepted aims in psychiatry, recently even in very early stages of the disorder when clear diagnostic criteria are not yet fulfilled. However, reliable and widely applicable methods do not yet exist. This study aims at contributing to the improvement of the early assessment of psychosis.


Acta Psychiatrica Scandinavica | 2006

Early detection and treatment of schizophrenia: how early?

Anita Riecher-Rössler; Ute Gschwandtner; S. Borgwardt; Jacqueline Aston; Marlon Pflüger; Wulf Rössler

Objective:  Whereas early detection and therapy of schizophrenic psychoses until some time ago concentrated on frank schizophrenia, during the last years some centres have also started to treat patients even before a clear diagnosis could be established. This paper attempts to discuss if and when this is justified in the light of recent research.


Acta Psychiatrica Scandinavica | 2003

Neuropsychological and neurophysiological findings in individuals suspected to be at risk for schizophrenia: preliminary results from the Basel early detection of psychosis study – Früherkennung von Psychosen (FEPSY)

Ute Gschwandtner; Jacqueline Aston; S. Borgwardt; M. Drewe; C. Feinendegen; D. Lacher; A. Lanzarone; Rolf-Dieter Stieglitz; Anita Riecher-Rössler

Objective: Our study aims to establish a scientific basis for the very early detection of patients at risk for schizophrenia during the nonspecific prodromal phase of the disorder and to predict its outbreak.


Schizophrenia Bulletin | 2016

The Dark Side of the Moon: Meta-analytical Impact of Recruitment Strategies on Risk Enrichment in the Clinical High Risk State for Psychosis

Paolo Fusar-Poli; Frauke Schultze-Lutter; Marco Cappucciati; Grazia Rutigliano; Ilaria Bonoldi; Daniel Stahl; S. Borgwardt; Anita Riecher-Rössler; Jean Addington; Diana O. Perkins; Scott W. Woods; Thomas H. McGlashan; James Lee; Joachim Klosterkötter; Alison R. Yung; Philip McGuire

Background: The individual risk of developing psychosis after being tested for clinical high-risk (CHR) criteria (posttest risk of psychosis) depends on the underlying risk of the disease of the population from which the person is selected (pretest risk of psychosis), and thus on recruitment strategies. Yet, the impact of recruitment strategies on pretest risk of psychosis is unknown. Methods: Meta-analysis of the pretest risk of psychosis in help-seeking patients selected to undergo CHR assessment: total transitions to psychosis over the pool of patients assessed for potential risk and deemed at risk (CHR+) or not at risk (CHR−). Recruitment strategies (number of outreach activities per study, main target of outreach campaign, and proportion of self-referrals) were the moderators examined in meta-regressions. Results: 11 independent studies met the inclusion criteria, for a total of 2519 (CHR+: n = 1359; CHR−: n = 1160) help-seeking patients undergoing CHR assessment (mean follow-up: 38 months). The overall meta-analytical pretest risk for psychosis in help-seeking patients was 15%, with high heterogeneity (95% CI: 9%–24%, I 2 = 96, P < .001). Recruitment strategies were heterogeneous and opportunistic. Heterogeneity was largely explained by intensive (n = 11, β = −.166, Q = 9.441, P = .002) outreach campaigns primarily targeting the general public (n = 11, β = −1.15, Q = 21.35, P < .001) along with higher proportions of self-referrals (n = 10, β = −.029, Q = 4.262, P = .039), which diluted pretest risk for psychosis in patients undergoing CHR assessment. Conclusions: There is meta-analytical evidence for overall risk enrichment (pretest risk for psychosis at 38monhts = 15%) in help-seeking samples selected for CHR assessment as compared to the general population (pretest risk of psychosis at 38monhts=0.1%). Intensive outreach campaigns predominantly targeting the general population and a higher proportion of self-referrals diluted the pretest risk for psychosis.


Translational Psychiatry | 2015

Increased functional connectivity in the resting-state basal ganglia network after acute heroin substitution.

André Schmidt; Niklaus Denier; Stefano Magon; Ernst Wilhelm Radue; Christian G. Huber; Anita Riecher-Rössler; Gerhard A. Wiesbeck; Undine E. Lang; S. Borgwardt; Marc Walter

Reinforcement signals in the striatum are known to be crucial for mediating the subjective rewarding effects of acute drug intake. It is proposed that these effects may be more involved in early phases of drug addiction, whereas negative reinforcement effects may occur more in later stages of the illness. This study used resting-state functional magnetic resonance imaging to explore whether acute heroin substitution also induced positive reinforcement effects in striatal brain regions of protracted heroin-maintained patients. Using independent component analysis and a dual regression approach, we compared resting-state functional connectivity (rsFC) strengths within the basal ganglia/limbic network across a group of heroin-dependent patients receiving both an acute infusion of heroin and placebo and 20 healthy subjects who received placebo only. Subsequent correlation analyses were performed to test whether the rsFC strength under heroin exposure correlated with the subjective rewarding effect and with plasma concentrations of heroin and its main metabolites morphine. Relative to the placebo treatment in patients, heroin significantly increased rsFC of the left putamen within the basal ganglia/limbic network, the extent of which correlated positively with patients’ feelings of rush and with the plasma level of morphine. Furthermore, healthy controls revealed increased rsFC of the posterior cingulate cortex/precuneus in this network relative to the placebo treatment in patients. Our results indicate that acute heroin substitution induces a subjective rewarding effect via increased striatal connectivity in heroin-dependent patients, suggesting that positive reinforcement effects in the striatum still occur after protracted maintenance therapy.


Psychopharmacology | 2013

Cannabis use and cognitive functions in at-risk mental state and first episode psychosis

Hilal Bugra; Erich Studerus; Charlotte Rapp; Corinne Tamagni; Jacqueline Aston; S. Borgwardt; Anita Riecher-Rössler

BackgroundMeta-analyses suggest that schizophrenia patients with a history of cannabis use have less impaired cognitive functioning compared to patients without cannabis use.AimsThe objective of this study was to assess the association between recency and frequency of cannabis use and cognitive functioning in at-risk mental state for psychosis (ARMS) and first episode psychosis (FEP) individuals.MethodsOne hundred thirty-six participants completed a cognitive test battery and were assessed for current and past cannabis use. Analyses of covariance models were applied to evaluate the main effects of cannabis use and patient group (ARMS vs. FEP) as well as their interactions on cognitive functioning.ResultsNo differences were observed in cognitive performance between current, former, and never users, and there were no significant interactions between cannabis use and patient group. Furthermore, within the group of current cannabis users, the frequency of cannabis use was not significantly associated with cognitive functioning.ConclusionThe results of the present study do not support the notion that FEP patients and ARMS individuals with a history of cannabis use have less impaired cognitive functioning compared to those without cannabis use.


Translational Psychiatry | 2016

Impact of polygenic schizophrenia-related risk and hippocampal volumes on the onset of psychosis

Fabienne Harrisberger; Renata Smieskova; Christian Vogler; Tobias Egli; André Schmidt; Claudia Lenz; Andor E. Simon; Anita Riecher-Rössler; Andreas Papassotiropoulos; S. Borgwardt

Alterations in hippocampal volume are a known marker for first-episode psychosis (FEP) as well as for the clinical high-risk state. The Polygenic Schizophrenia-related Risk Score (PSRS), derived from a large case–control study, indicates the polygenic predisposition for schizophrenia in our clinical sample. A total of 65 at-risk mental state (ARMS) and FEP patients underwent structural magnetic resonance imaging. We used automatic segmentation of hippocampal volumes using the FSL-FIRST software and an odds-ratio-weighted PSRS based on the publicly available top single-nucleotide polymorphisms from the Psychiatric Genomics Consortium genome-wide association study (GWAS). We observed a negative association between the PSRS and hippocampal volumes (β=−0.42, P=0.01, 95% confidence interval (CI)=(−0.72 to −0.12)) across FEP and ARMS patients. Moreover, a higher PSRS was significantly associated with a higher probability of an individual being assigned to the FEP group relative to the ARMS group (β=0.64, P=0.03, 95% CI=(0.08–1.29)). These findings provide evidence that a subset of schizophrenia risk variants is negatively associated with hippocampal volumes, and higher values of this PSRS are significantly associated with FEP compared with the ARMS. This implies that FEP patients have a higher genetic risk for schizophrenia than the total cohort of ARMS patients. The identification of associations between genetic risk variants and structural brain alterations will increase our understanding of the neurobiology underlying the transition to psychosis.


European Psychiatry | 2018

Long-term reduction of seclusion and forced medication on a hospital-wide level: Implementation of an open-door policy over 6 years

Lisa Hochstrasser; Daniela Fröhlich; Andres R. Schneeberger; S. Borgwardt; Undine E. Lang; Rolf-Dieter Stieglitz; Christian G. Huber

BACKGROUND Psychiatric inpatient treatment is increasingly performed in settings with locked doors. However, locked wards have well-known disadvantages and are ethically problematic. In addition, recent data challenges the hypothesis that locked wards provide improved safety over open-door settings regarding suicide, absconding and aggression. Furthermore, there is evidence that the introduction of an open-door policy may lead to short-term reductions in involuntary measures. The aim of this study was to assess if the introduction of an open-door policy is associated with a long-term reduction of the frequency of seclusion and forced medication. METHOD In this 6-year, hospital-wide, longitudinal, observational study, we examined the frequency of seclusion and forced medication in 17,359 inpatient cases admitted to the Department of Adult Psychiatry, Universitäre Psychiatrische Kliniken (UPK) Basel, University of Basel, Switzerland. In an approach to enable a less restrictive policy, six previously closed psychiatric wards were permanently opened beginning from August 2011. During this process, a systematic change towards a more patient-centered and recovery-oriented care was applied. Statistical analysis consisted of generalized estimating equations (GEE) models. RESULTS In multivariate analyses controlling for potential confounders, the implementation of an open-door policy was associated with a continuous reduction of seclusion (from 8.2 to 3.5%; ηp2=0.82; odds ratio: 0.88) and forced medication (from 2.4 to 1.2%; ηp2=0.70; odds ratio: 0.90). CONCLUSION This underlines the potential of the introduction of an open-door policy to attain a long-term reduction in involuntary measures.


European Psychiatry | 2013

2989 – Structural and functional neuroimaging in early schizophrenia: translating research evidence into clinical utility

S. Borgwardt

Early clinical detection and intervention in schizophrenia has recently become a major objective of mental health services, while research on the early phases of the disorder may provide important clues to the pathophysiology underlying schizophrenia. Thus, the identification of a clinical syndrome that reflect a predisposition to schizophrenia is fundamental from a clinical and a research perspective. The onset of schizophrenia is usually preceded by a prodromal phase characterized by functional decline and subtle prodromal symptoms. However, clinical criteria currently employed to define a high-risk mental state for psychosis have relatively low validity and specificity. Consequently there is an urgent need of reliable biomarkers that underlie schizophrenia. Structural and functional neuroimaging methods have rapidly developed into a powerful tool in biological psychiatry as they provide an unprecedented opportunity for the investigation of brain structure and function. In this core-symposium it will be aimed to show that neuroimaging studies of the prodromal phases of psychosis have the potentials to identify core structural and functional markers of vulnerability to psychosis and to clarify the ongoing changes during the transition from high-risk to first episode psychosis.

Collaboration


Dive into the S. Borgwardt's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paolo Brambilla

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

View shared research outputs
Researchain Logo
Decentralizing Knowledge